| Title | International Journal of Hematology-Oncology and Stem Cell Research |
| Abbreviation | Int. J. Hematol.-Oncol. Stem Cell Res. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Transplantation (Q3); Hematology (Q4); Oncology (Q4) |
| h-index | 21 |
| Overall Rank/Ranking | 17980 |
| SCImago Journal Rank (SJR) | 0.224 |
| Impact Score | 0.66 |
| Publisher | Tehran University of Medical Sciences |
| Country | Iran |
| ISSN | 17351243, 20082207 |
| Best Quartile | Q3 |
| Coverage History | 2009-2022 |
International Journal of Hematology-Oncology and Stem Cell Research is a journal covering the technologies/fields/categories related to Transplantation (Q3); Hematology (Q4); Oncology (Q4). It is published by Tehran University of Medical Sciences. The overall rank of International Journal of Hematology-Oncology and Stem Cell Research is 17980. According to SCImago Journal Rank (SJR), this journal is ranked 0.224. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 21. The best quartile for this journal is Q3.
The ISSN of International Journal of Hematology-Oncology and Stem Cell Research journal is 17351243, 20082207. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. International Journal of Hematology-Oncology and Stem Cell Research is cited by a total of 86 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of International Journal of Hematology-Oncology and Stem Cell Research is 0.66, which is computed in 2023 as per its definition. International Journal of Hematology-Oncology and Stem Cell Research IF is decreased by a factor of 0.14 and approximate percentage change is -17.5% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of International Journal of Hematology-Oncology and Stem Cell Research is 0.66. If the same downward trend persists, Impact IF may fall in 2023 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 0.66 |
| 2021 | 0.80 |
| 2020 | 0.89 |
| 2019 | 1.57 |
| 2018 | 1.38 |
| 2017 | 1.48 |
| 2016 | 1.33 |
| 2015 | 1.29 |
| 2014 | 0.40 |
International Journal of Hematology-Oncology and Stem Cell Research has an h-index of 21. It means 21 articles of this journal have more than 21 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of International Journal of Hematology-Oncology and Stem Cell Research is 17351243, 20082207. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of International Journal of Hematology-Oncology and Stem Cell Research is 17980. According to SCImago Journal Rank (SJR), this journal is ranked 0.224. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 0.224 |
| 2021 | 0.239 |
| 2020 | 0.436 |
| 2019 | 0.494 |
| 2018 | 0.418 |
| 2017 | 0.560 |
| 2016 | 0.431 |
| 2015 | 0.299 |
| 2014 | 0.135 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 17980 |
| 2021 | 16849 |
| 2020 | 11304 |
| 2019 | 9894 |
| 2018 | 10970 |
| 2017 | 8381 |
| 2016 | 10432 |
| 2015 | 13421 |
| 2014 | 22188 |
International Journal of Hematology-Oncology and Stem Cell Research is published by Tehran University of Medical Sciences. It's publishing house is located in Iran. Coverage history of this journal is as following: 2009-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of International Journal of Hematology-Oncology and Stem Cell Research is Int. J. Hematol.-Oncol. Stem Cell Res.. This abbreviation ('Int. J. Hematol.-Oncol. Stem Cell Res.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Transplantation (Q3); Hematology (Q4); Oncology (Q4), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
International Journal of Hematology-Oncology and Stem Cell Research latest impact IF is 0.66. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 1.57 (2019) and 0.40 (2014), respectively, in the last 9 years. Moreover, its average IS is 1.09 in the previous 9 years.
The International Journal of Hematology-Oncology and Stem Cell Research has an SJR (SCImago Journal Rank) of 0.224, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 0.560 in 2017 and the lowest being 0.135 in 2014. Furthermore, the average SJR of the International Journal of Hematology-Oncology and Stem Cell Research over the previous 9-year period stands at 1.09.
The latest h-index of the International Journal of Hematology-Oncology and Stem Cell Research is 21.
The International Journal of Hematology-Oncology and Stem Cell Research is published by the Tehran University of Medical Sciences, with its country of publication being the Iran.
The International Journal of Hematology-Oncology and Stem Cell Research is currently ranked 17980 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 8381 in 2017 and its lowest position of 22188 in 2014.
The standard ISO4 abbreviation for the International Journal of Hematology-Oncology and Stem Cell Research is Int. J. Hematol.-Oncol. Stem Cell Res..
International Journal of Hematology-Oncology and Stem Cell Research is classified as a journal that the Tehran University of Medical Sciences publishes.
The International Journal of Hematology-Oncology and Stem Cell Research encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The International Journal of Hematology-Oncology and Stem Cell Research is assigned the following International Standard Serial Numbers (ISSN): 17351243, 20082207.
The best quartile for the International Journal of Hematology-Oncology and Stem Cell Research is Q3 (2022).
The International Journal of Hematology-Oncology and Stem Cell Research coverage history can be summarized as follows: 2009-2022.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Indian Journal of Plastic Surgery | journal | 16018 | Thieme Medical Publishers Inc. | 37 | 0.65 |
| Analysis in Theory and Applications | journal | 19346 | Springer Netherlands | 11 | 0.00 |
| Journal of Applied Business Research | journal | 23890 | 29 | 0.28 | |
| Archives of Phytopathology and Plant Protection | journal | 14852 | Taylor and Francis Ltd. | 29 | 1.14 |
| Discourse | journal | 6621 | Routledge | 59 | 2.11 |
| British Journal of Special Education | journal | 12024 | Wiley-Blackwell Publishing Ltd | 42 | 1.24 |
| Transnational Corporations | journal | 6120 | UNCTAD United Nations Conference on Trade and Development | 27 | 1.92 |
| Natural Solutions | trade journal | 28581 | Innovision Health Media | 1 | 0.00 |
| Proceedings of the Technical Association of the Graphic Arts, TAGA | conference and proceedings | 30903 | Technical Association of the Graphic | 8 | 0.00 |
| Indian Phytopathology | journal | 14222 | Springer Nature | 11 | 1.33 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 0.66 |
| 2021 | 0.80 |
| 2020 | 0.89 |
| 2019 | 1.57 |
| 2018 | 1.38 |
| 2017 | 1.48 |
| 2016 | 1.33 |
| 2015 | 1.29 |
| 2014 | 0.40 |
